Effects of enalapril and imidapril in the capsaicin cough challenge test and spirometry parameters in healthy volunteers

Therapy

Volumn 1, Issue 2, 2004, Pages 223-230

  Silveria, Pedro ^a   Vaz da Silva, Manuel ^a   Maia, Joana ^a   Almeida, Luis ^a   Gama, Helena ^a   Soares da Silva, Patrício ^a  

^a DEPARTMENT OF RESEARCH AND DEVELOPMENT   (Portugal)

Author keywords

Capsaicin; Cough; Enalapril; Healthy volunteers; Imidapril; Spirometry

Indexed keywords

CAPSAICIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IMIDAPRIL; PLACEBO; SODIUM CHLORIDE;

ADULT; ARTICLE; ASTHENIA; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; HUMAN EXPERIMENT; INSOMNIA; MALE; NORMAL HUMAN; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SEQUENTIAL ANALYSIS; SOMNOLENCE; SPIROMETER; SPIROMETRY; STATISTICAL SIGNIFICANCE; VOLUNTEER;

EID: 23944524433     PISSN: 14750708     EISSN: None     Source Type: Journal    
DOI: 10.1586/14750708.1.2.223     Document Type: Article

References (38)

1. Angiotensin-Converting Enzyme (ACE) Inhibitors (Systemic). In: USP DI-Volume 1 Drug Information for the Health Care Professional, Micromedex Thomson Healthcare, Greenwood Village, 202-214 (2002).
2. Overlack A. ACE inhibitor-induced cough and bronchospasm. Drug Safety 15, 72-78 (1996).
3. Takahama K, Araki T, Fuchikami J. et al. Studies on the magnitude and the mechanism of cough potentiation by angiotensin-converting enzyme inhibitors in guinea-pigs: involvement of bradykinin in the potentiation. J. Pharm. Pharmacol. 48, 1027-1033 (1996).
4. Luque CA, Ortiz MV. Treatment of ACE inhibitor-induced cough. Pharmacotherapy 19, 804-810 (1999).
5. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann. Intern. Med. 117, 234-242 (1992).
6. 2 synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitors. Life Science 1583-1588 (1997).
7. Saruta T, Omae T, Kuramochi M et al. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control. J. Hypertens. 13(Suppl. 3), 523-530 (1995).
8. Sasaguri T, Ideishi M, Kinoshita A et al. Differential inhibition of bradykinin hydrolysis by four ACE inhibitors: a possible explanation for differences in induced coughing. Hypertens. Res. 17, 253-258 (1994).
9. Midgren B, Hanson L, Karlsson JA et al. Capsaicin-induced cough in humans. Am. Rev. Respir. Dis. 146, 347-351 (1992).
10. Laloo UG, Lim S, DuBois R et al. Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease. Eur. Respir. J. 11, 702-705 (1998).
11. Doherty MJ, Mister R, Pearson MG et al. Capsaicin responsiveness and cough in asthma and chronic obstructive pulmonary disease. Thorax 55, 643-649 (2000).
12. Fujimura M, Sakamoto S, Kamio Y et al. Effect of methacholine induced bronchoconstriction and procaterol induced bronchodilation on cough receptor sensitivity to inhaled capsaicin and tartaric acid. Thorax 47, 441-445 (1992).
13. Semple PF, Herd GW. Cough and wheeze caused by inhibitors of angiotensin-converting enzyme. N. Engl. J. Med. 314, 61 (1986).
14. Popa V. Captopril-related (and -induced?) asthma. Am. Rev. Respir. Dis. 136, 999-1000 (1987).
15. Knudson RJ, Lebowitz M D, Holberg CJ et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am. Rev. Respir. Dis. 127, 725-734 (1983).
16. Ferguson RK, Masses PH, Rotmensch HH. Clinical applications of angiotensin-converting enzyme inhibitors. Am. J. Med. 77, 690-698 (1984).
17. The sixth report of the Joint National Committee on prevention, detection, evaluation, and twatment of high blood pressure. National Institutes of Health. NIH Publication No. 98-4080, Bethesda, USA (1997).
18. Andersson RGG, Persson K. ACE inhibitors and their influence on inflammation, bronchial reactivity and cough. Eur. Heart J. 15(Suppl. C), S52-S56 (1994).
19. Semple PF. Putative mechanisms of cough after treatment with angiotensin converting enzyme inhibitors. J. Hypert. 13(Suppl. 3), S17-S21 (1995).
20. Lunde H, Hedner T, Samuelsson O et al. Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. Br. Med. J. 308, 18-21 (1994).
21. Wood R. Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study. Br. J. Clin. Pharmacol. 39, 265-270 (1995).
22. Bucknall CE, Neilly JB, Carter R et al. Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors. Br. Med. J. (Clin. Res. Ed.). 296, 86-88 (1988).
23. Todd PA, Goa KL. Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension. Drugs 43, 346-381 (1992).
24. Erdos E. Angioterisin I converting enzyme and the changes in our concepts through the years. Hypertension 16, 363-370 (1990).
25. Nishikawa Y, Ogawa S. Incidence of cough induced by imidapril in patients with hypertension with enalapril-associated cough. Curr. Ther. Res. 58, 601-608 (1997).
26. Morice A, Lowry R, Brown M et al. Angiotensin-converting enzyme and the cough reflex. Lancet 1116-1118 (1987).
27. Fuller R, Choudry N. Increased cough reflex associated with angiotensin converting enzyme inhibitor cough. Br. Med. J. 294, 1025-1026 (1987).
28. Dicpinigaitis P, Dobkin J. Antitussive effect of the GABA-agonist baclofen. Chest 111, 996-999 (1997).
29. Fujimura M, Kamio Y, Hashimoto T et al. Cough receptor sensitivity and bronchial responsiveness in patients with only chronic nonproductive cough: in view of effect of bronchodilator therapy. J. Asthma 31, 463-472 (1994).
30. Dicpinigaitis P. Effect of zafirlukast, a leukotrien-receptor antagonist, on cough reflex sensitivity in healthy volunteers: a pilot study. Curr. Ther. Res. 60, 15-19 (1999).
31. Takahashi T, Yamaguchi E, Furuya K et al. The ACE gene polymorphism and cough threshold for capsaicin after cilazapril usage. Respir. Med. 95, 130-135 (2001).
32. McGarvey L, Savage D, Feeney A et al. Is there an association between angiotensin-converting enzyme gene variants and chronic non-productive cough? Chest 118, 1091-1094 (2000).
33. Dicpinigaitis P, Dobkin J. Effects of angiotensin-converting enzyme inhibition on bronchial responsiveness. J. Clin. Pharmacol. 36, 361-364 (1996).
34. Packard K, Wurdeman R, Arouni A. ACE inhibitor induced bronchial reactivity in patients with respiratory disfunction. Ann. Pharmacother. 36, 1058-1067 (2002).
35. Morice AH, Kastelik JA, Thompson R. Cough challenge in the assessment of cough reflex. Br. J. Clin. Pharmacol. 52, 365-375 (2001).
36. Fuller RW, Dixon CM, Barnes PJ. Bronchoconstrictor response to inhaled capsaicin in humans. J. Appl. Physiol. 58, 1080-1084 (1985).
37. Hathaway TJ, Higenbottam TW, Morrison JF et al. Effects of inhaled capsaicin in heart-lung transplant patients and asthmatic subjects. Am. Rev. Respir. Dis. 148, 1233-1237 (1993).
38. Nieto Cabrera ML, de Diego Damiá A, Perpiñá Tordera M et al. Test de provocación tusígena con capsaicina: resultados en una población sana (Cough-inducing capsaicin challenge test in a healthy population). Archivos de Bronconeumología 37, 292-296 (2001).